Select Page

The North America region is dominating the RNA sequencing during the forecast period, 2019-2028. Growth in this region can be attributed to the presence of prominent market players in the U.S. and the growing adoption of next-generation sequencing in diagnostics and research. Additionally, the growing prevalence of genetic and chronic diseases coupled with significant research and development expenditure are some of the factors leading to the dominance of North America in the global RNA sequencing market.
BIS Research Report of RNA Sequencing

The Asia-Pacific region is anticipated to witness a high CAGR during the forecast period 2019-2028. The growth in the Asia-Pacific market is expected to be further multiplexed by various factors such as increasing healthcare awareness coupled with an increase in the utilization of sequencing techniques, including RNA sequencing, to improvise diagnostic and therapeutic research.